A group‐sequential randomized trial design utilizing supplemental trial data-Reference-Cited by-同舟云学术

A group‐sequential randomized trial design utilizing supplemental trial data

Published:2021-11-09 Issue:4 Volume:41 Page:698-718
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statistics in Medicine

Author:

Kotalik Ales¹^ORCID,Vock David M.²,Hobbs Brian P.³^ORCID,Koopmeiners Joseph S.²^ORCID

Affiliation:

1. Biometrics, Late‐stage Development, Respiratory and Immunology (R&I) AstraZeneca BioPharmaceuticals R&D Gaithersburg Maryland USA

2. Division of Biostatistics, School of Public Health University of Minnesota Minneapolis Minnesota USA

3. Dell Medical School The University of Texas at Austin Austin Texas USA

Funder

National Cancer Institute

National Heart, Lung, and Blood Institute

National Institute on Drug Abuse

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.9249

Reference51 articles.

1. Adaptive clinical trials in oncology

2. Adaptive Design Methods in Clinical Trials

3. Comments on the Draft Guidance on “Adaptive Design Clinical Trials for Drugs and Biologics” of the U.S. Food and Drug Administration

4. Food US.Food and drug administration. master protocols: efficient clinical trial design strategies to expedite development of oncology drugs and biologics guidance for industry‐draft guidance. draft guidance; 2018.

5. New “21st Century Cures” Legislation

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Propensity score weighted multi‐source exchangeability models for incorporating external control data in randomized clinical trials;Statistics in Medicine;2024-06-24

2. A Bayesian platform trial design with hybrid control based on multisource exchangeability modelling;Statistics in Medicine;2024-04-09